Clonazepam Tablet
Accord Healthcare Inc.
Open FDA's page for this record- Update type
- Revised
- Initial posting date
- 03/10/2023
- Change date
- 11/04/2026
- Package NDC
- 16729-136-00
- Generic name
- Clonazepam Tablet
- Contact info
- 866-941-7875, option 2
- Resolved note
- Available
- Update date
- 11/04/2026
- Dosage form
- Tablet
- Presentation
- Clonazepam, Tablet, .5 mg (NDC 16729-136-00)
- Company name
- Accord Healthcare Inc.
- Status
- Resolved
- Therapeutic category
- Neurology, Pediatric, Psychiatry
- Harmonized identifiers (openFDA)
- Application number
- ANDA077147
- Brand name
- CLONAZEPAM
- Generic name
- CLONAZEPAM
- Manufacturer name
- Accord Healthcare Inc.
- Product NDC
- 16729-136, 16729-137, 16729-138
- Product type
- HUMAN PRESCRIPTION DRUG
- Route
- ORAL
- Substance name
- CLONAZEPAM
- RxCUI
- 197527, 197528, 197529
- SPL ID
- 0e1e7f41-f78b-27cf-e063-6394a90a1ae0
- SPL set ID
- ebc11109-e7bf-452d-b675-4b3236d54164
- Package NDC
- 16729-136-00, 16729-136-16, 16729-137-00, 16729-137-16, 16729-138-00, 16729-138-16
- Nui
- N0000175694, M0002356
- Pharm class epc
- Benzodiazepine [EPC]
- Pharm class cs
- Benzodiazepines [CS]
- UNII
- 5PE9FDE8GB